Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
ConclusionsFor managing advanced HCC with PVTT, HAIC may be a valuable treatment modality.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Children | Drugs & Pharmacology | Hepatocellular Carcinoma | Liver Cancer | Study | Thrombosis